
Drug regulators should switch to adaptive pathways as the preferred approach to bringing future new medicines to patients, according to …
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?

